This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …

Despite major improvements in outcome over the past decades, acute myeloid leukemia
(AML) remains a life-threatening malignancy in children, with current survival rates of∼ …

Leukemias diagnosed in the first 12 months of life are characterized by an equal distribution
of lymphoid and myeloid subtypes and account for 2.5% to 5% of acute lymphoblastic …

Acute myeloid leukemia (AML) is a heterogeneous group of leukemias that result from clonal
transformation of hematopoietic precursors through the acquisition of chromosomal …

Outcomes of patients with acute myeloid leukemia (AML) improve significantly by
intensification of induction. To further intensify anthracycline dosage without increasing …

ContextCurrent treatment for acute myeloid leukemia (AML) in children cures about half the
patients. Of the other half, most succumb to leukemia, but 5% to 15% die of treatment-related …

Purpose The rates of early death (ED) and treatment-related mortality (TRM) are
unacceptably high in children undergoing intensive chemotherapy for acute myeloid …

A total of 1111 children with acute myeloblastic leukaemia (AML) were treated in four
consecutive Berlin–Frankfurt–Münster (BFM) studies from 1978 to 1998. The first …

From the bestselling author, Barbara J. Bain, the new edition of this practical reference on
the principles of leukaemia diagnosis and classification has been fully updated, and …

FLT3 is a receptor tyrosine kinase involved in the proliferation and differentiation of
hematopoietic stem cells. FLT3 internal tandem duplications (FLT3/ITDs) are reported in …